Literature DB >> 1337382

Biliary tract invasion and obstruction by hepatocellular carcinoma: report of five cases.

S T Lai1, K T Lam, K C Lee.   

Abstract

Major biliary tract obstruction caused by tumour invasion is a rare manifestation of hepatocellular carcinoma. The authors had the opportunity to diagnose and treat five such cases, three of whom had features of acute cholangitis. The prevalence of both hepatocellular carcinoma and recurrent pyogenic cholangitis is high in patients from the Far East. The former may first present under the guise of the latter. Gastroenterologists and surgeons should be aware of hepatocellular carcinoma when managing these patients who present with obstructive jaundice, gross hepatomegaly and cholangitis.

Entities:  

Mesh:

Year:  1992        PMID: 1337382      PMCID: PMC2399498          DOI: 10.1136/pgmj.68.806.961

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  18 in total

1.  Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies.

Authors:  H A EDMONDSON; P E STEINER
Journal:  Cancer       Date:  1954-05       Impact factor: 6.860

2.  Common bile duct obstruction by hepatoma.

Authors:  Y Kuroyanagi; M Sawada; R Hidemura; S Aoki; H Kato
Journal:  Am J Surg       Date:  1977-02       Impact factor: 2.565

Review 3.  Obstructive jaundice caused by hepatoma fragments in the common hepatic duct.

Authors:  J Kiev; D C Dyslin; P Vitenas; M D Kerstein
Journal:  J Clin Gastroenterol       Date:  1990-04       Impact factor: 3.062

4.  Hepatoma with obstructive jaundice due to the migration of a tumor mass in the biliary tract: report of a successful resection.

Authors:  T Tsuzuki; Y Ogata; S Iida; M Kasajima; S Takahashi
Journal:  Surgery       Date:  1979-05       Impact factor: 3.982

5.  Clinical manifestations of hepatoma. A review of 6 years' experience at a cancer hospital.

Authors:  D C Ihde; P Sherlock; S J Winawer; J G Fortner
Journal:  Am J Med       Date:  1974-01       Impact factor: 4.965

6.  Cholangiography in hepatocellular carcinoma with obstructive jaundice.

Authors:  N W Lee; K P Wong; K F Siu; J Wong
Journal:  Clin Radiol       Date:  1984-03       Impact factor: 2.350

Review 7.  Resection of hepatocellular carcinoma with obstructive jaundice caused by compression of the common hepatic duct.

Authors:  K C Lee; K Sakai; H Kinoshita; K Hirohashi; Y Tsuji; S Kubo; R Iwasa
Journal:  J Surg Oncol       Date:  1988-11       Impact factor: 3.454

8.  Small hepatocellular carcinoma presenting as intrabiliary pedunculated polyp and obstructive jaundice.

Authors:  T Terada; Y Nakanuma; K Kawai
Journal:  J Clin Gastroenterol       Date:  1989-10       Impact factor: 3.062

9.  Hepatocellular carcinoma presenting as intrabile duct tumor growth: a clinicopathologic study of 24 cases.

Authors:  M Kojiro; K Kawabata; Y Kawano; F Shirai; N Takemoto; T Nakashima
Journal:  Cancer       Date:  1982-05-15       Impact factor: 6.860

10.  Bile obstruction in hepatocellular carcinoma--visualization by endoscopic retrograde cholangiography. A case report.

Authors:  M R Moosa; I Segal; A Mannell; J H Hodkinson; A Paterson
Journal:  S Afr Med J       Date:  1984 Dec 22-29
View more
  6 in total

1.  Clinicopathologic characteristics of hepatocellular carcinoma with bile duct invasion.

Authors:  Naoki Ikenaga; Kazuo Chijiiwa; Kazuhiro Otani; Jiro Ohuchida; Shuichiro Uchiyama; Kazuhiro Kondo
Journal:  J Gastrointest Surg       Date:  2008-11-15       Impact factor: 3.452

2.  A logical approach to hepatocellular carcinoma presenting with jaundice.

Authors:  W Lau; K Leung; T W Leung; C T Liew; M S Chan; S C Yu; A K Li
Journal:  Ann Surg       Date:  1997-03       Impact factor: 12.969

3.  ERCP and stent therapy for progressive jaundice in hepatocellular carcinoma: which patients benefit, which patients don't?

Authors:  J A Martin; A Slivka; M Rabinovitz; B I Carr; J Wilson; W B Silverman
Journal:  Dig Dis Sci       Date:  1999-07       Impact factor: 3.199

Review 4.  Hepatocellular carcinoma with obstructive jaundice: diagnosis, treatment and prognosis.

Authors:  Lun-Xiu Qin; Zhao-You Tang
Journal:  World J Gastroenterol       Date:  2003-03       Impact factor: 5.742

5.  The endoscopic retrograde cholangiopancreatographic manifestations of histopathologically diagnosed hepatocellular carcinoma with obstructive jaundice.

Authors:  Qiu Zhao; Biao Gong; Naixi Lu; Nanzhi Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2002

6.  Surgical outcome of hepatocellular carcinoma patients with biliary tumor thrombi.

Authors:  Wenyu Shao; Chengjun Sui; Zhenyu Liu; Jiamei Yang; Yanming Zhou
Journal:  World J Surg Oncol       Date:  2011-01-08       Impact factor: 2.754

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.